A5060240121- Ovarian cancer diagnosis and treatment
- Reproductive Biology and Fertility
- Ovarian function and disorders
- Reproductive Health and Technologies
- Gynecological conditions and treatments
- Assisted Reproductive Technology and Twin Pregnancy
- Maternal and fetal healthcare
- Testicular diseases and treatments
- Sarcoma Diagnosis and Treatment
- Childhood Cancer Survivors' Quality of Life
- Sexual Differentiation and Disorders
- Endometriosis Research and Treatment
- Ethics and Legal Issues in Pediatric Healthcare
- Enhanced Recovery After Surgery
- Cardiac, Anesthesia and Surgical Outcomes
- Hematopoietic Stem Cell Transplantation
- Intestinal and Peritoneal Adhesions
- Urological Disorders and Treatments
- Urologic and reproductive health conditions
- Renal and related cancers
- Female Genital Mutilation/Cutting Issues
- Hernia repair and management
- Blood Coagulation and Thrombosis Mechanisms
- Child Abuse and Related Trauma
- Cardiovascular Issues in Pregnancy
University of Utah
2023-2024
Emory University
2018-2023
Federal Reserve
2023
Children's Healthcare of Atlanta
2018-2023
Primary Children's Hospital
2023
Baylor College of Medicine
2016-2020
Surgical Specialties (United States)
2020
Texas Children's Hospital
2016-2017
Northwestern University
2013-2015
Illinois College
2010
Background Heavy menstrual bleeding (HMB) is often the first symptom for female individuals with inherited disorders. Guidelines recommend performing hemostatic evaluation at HMB presentation. Von Willebrand factor (VWF) levels increase stress, making it unclear if VWF studies during acute are beneficial in diagnosing von disease (VWD). Objectives To determine utility of testing VWD HMB. Patients/Methods This retrospective cohort study evaluated presenting to emergency department (ED) from...